SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-040813
Filing Date
2019-07-17
Accepted
2019-07-17 19:38:19
Documents
2
Period of Report
2019-07-17

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 3515
2 EX-24.1 ex-24d1.htm EX-24.1 8635
  Complete submission text file 0001104659-19-040813.txt   13486
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Thomson Peter G. (Reporting) CIK: 0001779120 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38978 | Film No.: 19960180